Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets

Lorenzo Norsa1, Raanan Shamir, Noam Zevit

  • 1Lorenzo Norsa, Elvira Verduci, Diana Ghisleni, Enrica Riva, Marcello Giovannini, Department of Pediatrics, San Paolo Hospital University of Milan, 20142 Milan, Italy.

Insights

Children with celiac disease (CD) on a gluten-free diet (GFD) show increased cardiovascular disease (CVD) risk factors, including high triglycerides and borderline LDL cholesterol. This highlights the need for CVD screening and dietary counseling in these patients.

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Cardiovascular Health

Background:

  • Celiac disease (CD) requires a strict gluten-free diet (GFD).
  • Long-term adherence to GFD may influence metabolic health.
  • Cardiovascular disease (CVD) risk factors in children with CD are not fully understood.

Purpose of the Study:

  • To assess cardiovascular disease (CVD) risk factors in children diagnosed with celiac disease (CD) and adhering to a gluten-free diet (GFD).
  • To compare CVD risk factors in CD patients on a GFD with their baseline values at diagnosis.

Main Methods:

  • A cross-sectional, multicenter study involving 114 children with CD in serologic remission on a GFD for at least one year.
  • Measurements included anthropometrics, blood lipids, glucose, and calculation of insulin resistance (HOMA-IR).
  • Data were compared to baseline values at diagnosis.

Main Results:

  • 14% of children on a GFD had three or more CVD risk factors.
  • Common risk factors included high triglycerides (34.8%), elevated blood pressure (29.4%), and borderline LDL cholesterol (24%).
  • Trends showed increased overweight and obesity rates on GFD, with higher insulin resistance noted in one cohort.

Conclusions:

  • Children with celiac disease on a gluten-free diet exhibit significant cardiovascular disease risk factors.
  • Routine screening for CVD risk factors is crucial for pediatric CD patients.
  • Targeted dietary counseling is essential for CVD prevention in this population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...